Aspire-Lakewood Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
Q3 2025 vs. Q2 2025
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 31 | 2 | 31 | +2 |
| Shares | 7.74M | 437.1K | 7.74M | +433.1K (+5.9%) |
| Value | $395.1K | $19.5K | $246.3K | −$129.3K (−34.4%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street Group Inc. | 437,264 | $13.1K | 0.00% |
| Antara Capital LP | 207,693 | $6.21K | 1.27% |
| Crossingbridge Advisors, LLC | 49,846 | $2.79K | 0.00% |
| Susquehanna International Group, LLP | 57,932 | $1.73K | 0.00% |
Sold out (2)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Taconic Capital Advisors LP | 300,000 | $13.4K |
| Athos Capital Ltd | 21,383 | – |
Not filed for Q3 2025 yet (2)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 331,064 | $14.8K |
| Clear Street Derivatives LLC | 106,000 | $4.74K |